- Home
- NEWS
- REGIONAL
- THIS WEEK'S PAPER
- BLOGS
- Multimedia
- OPINION
- A&E
- LISTS
- PEOPLE
- EVENTS
- Classifieds
- Subscribe
Health Care Businesses
Cook predicts blockbuster with new stent
August 12, 2009
J.K. WallBloomington-based Cook Medical has won European approval for a new artery-opening device for the legs that it predicts will
be a blockbuster.
MoreLilly software spinoff Maaguzi sells for $11 million
August 3, 2009
Chris O'MalleyInvestors in a company built around clinical research software bought from Eli Lilly and Co. have found their exit, though
it’s far from the lucrative payoff they’d once imagined.
MoreVIEWPOINT: CEOs, do you deserve your salaries?
June 22, 2009
John GuyAn exaggerated share of the nation's wealth is paid to CEOs of public companies, their minions and directors, through agreements
made inside boardrooms, by highly compensated individuals who commit shareholders' money and are not subject to effective
oversight.
MoreSimple invention targets blanket problem for surgical patients
May 25, 2009
Chris O'MalleyIn a state steeped in advanced research that spawns biomedical companies by the dozen, Apricity LLC is preposterously low-tech,
given that its latest product is nothing more than a warm blanket.
MoreObama's reforms could bite Lilly
April 20, 2009
When it comes to health care reform, Eli Lilly and Co. has its derriere exposed more than its drugmaker peers.
MoreDoctors should adapt to ratings
April 13, 2009
Rating doctors via online services helps consumers make better health care decisions.
MoreDoctors squirm as patients rate health care
April 6, 2009
J.K. WallAs health care slowly shifts to operate more like retail stores, patients' opinions of doctors have become commonplace on
more than 30 physician-rating Web sites, including a subscription service run by Indianapolis-based Angie's List.
MoreExecutives make many trips to Washington to argue for 14 years of sales exclusivity for new drugs made from cells
March 23, 2009
J.K. WallEli Lilly & Co. executives are making many trips to Washington to argue for 14 years of sales exclusivity for new drugs made
from cells.
MoreAIT Laboratories named 'Small Business of the Year'
March 2, 2009
The Indiana Chamber of Commerce has named Indianapolis-based health care research and testing firm AIT Laboratories its 2009
Small Business of the Year.
MoreAfter two decades, future bright for Catheter Research Inc.
February 23, 2009
J.K. WallCatheter Research Inc. now is flying high—even in the midst of a bad economy.
MoreStartup NICO raises another $1.73M
February 16, 2009
Indianapolis-based medical-device startup NICO Corp. has raised $1.73 million from investors.
MoreHealth care interests wary of state's cost-cutting idea for Medicaid
February 9, 2009
J.K. WallIndiana Medicaid officials want to take over management of all its patients' prescription drugs because they say it could
save the state as much as $40 million a year.
MoreEntrepreneurs pursuing patient advocacy trend
February 2, 2009
Christopher LloydPatients are seeking help with their doctors, records and referrals as the health care system grows increasingly complex.
MoreStimulus could help medical exchange
February 2, 2009
President Barack Obama's economic stimulus bill provides a big opportunity for the Indianapolis-based Indiana Health Information Exchange to spread its expertise around the country.
Lilly settles Zyprexa marketing suit for $1.4 billion
January 15, 2009
J.K. WallIndianapolis-based Lilly pleaded guilty to one violation of the Food, Drug and Cosmetic Act on Thursday and agreed to pay
$1.42 billion to settle both that criminal charge as well as civil lawsuits in which it did not admit wrongdoing.
MoreMy Health Care Manager goes national
December 15, 2008
Less than three years into its life, Indianapolis-based My Health Care Manager is going national.
MoreLilly fighting with generic drug firms over Cymbalta, Alimta, 5 other medications
December 8, 2008
J.K. WallEli Lilly & Co. has filed lawsuits against seven generic drug companies in federal court in Indianapolis, asking a judge to
declare its Cymbalta patent valid and to tell the generic companies to back off.
MoreBillingsley markets health care mystery shopping business
December 8, 2008
Della PachecoAs co-founder and head of sales and marketing, Brooke Billingsley has helped build Indianapolis-based Perception Strategies
Inc. — a health
care mystery shopping business co-founded by her husband, Kevin.
MoreEli Lilly investing $100M in China, hoping to attract research partners
December 1, 2008
Brian SpegeleHoping to increase sales in China's rapidly growing pharmaceutical market, Eli Lilly and Co. is charging ahead
with
plans to invest $100 million in venture capital in the region over the next several years.
MoreIndianapolis eye surgeon popularizes new transplant technique
November 10, 2008
J.K. WallDr. Francis Price Jr. has brought hundreds of eye surgeons to Indianapolis to train them in how to use
a new cornea transplant technique that has swept the ophthalmology field—DSEK, which stands
for Descemet's stripping endothelial keratoplasty.
MoreSt. Francis Hospitals, Anthem disagree over health insurance reimbursements
November 10, 2008
The St. Francis hospital system and Anthem Blue Cross and Blue Shield of Indiana are haggling over insurance reimbursement
costs. The original demand of Sisters of St. Francis Health Services Inc. would have increased reimbursement amounts $80 million
over three years, Rick Rhodes, an Anthem regional vice president, wrote in an Oct. 30 letter to employers covered by Anthem.
The increase would mean $12 million more in out-of-pocket costs to Anthem customers. But St. Francis claims its request for
an increase only brings it in line with what other hospitals are getting.
MoreLilly buys ImClone as part of strategy to capitalize on cancer-drug market
October 13, 2008
J.K. WallEli Lilly and Co. has written a $6.5 billion IOU to acquire the cancer drugs of ImClone Systems Inc. Cancer drugs are now the best-selling class of drugs in the world and one of the fastest growing.
Lilly taps hedge fund to cut research costs for Alzheimer's drugs
August 11, 2008
J.K. WallEli Lilly and Co.'s unorthodox efforts to develop new treatments for Alzheimer's disease--if successful--could usher in a new approach to drug development. The Indianapolis-based pharmaceutical company announced that a New York hedge fund, TPG-Axon Capital, will invest up to $325 million to help cover the exorbitant development costs of two experimental compounds to treat Alzheimer's disease.
Lilly expects FDA approval of long-acting version of Zyprexa
February 4, 2008
J.K. WallEli Lilly and Co. hopes to extend the life of its best-seller Zyprexa with a potentially lucrative, long-acting form of the
antipsychotic drug. But first, the Indianapolis-based drugmaker must win over a panel of medical experts convened by the U.S.
Food and Drug Administration on Feb. 6.
More
Sponsored by
ADVERTISEMENT
on Facebook & Twitter
on Facebook & Twitter
 Follow IBJ's Tweets on these topics: |
||
| @IBJNews | @Propertylines | @IBJTheScore |
| @IBJArts | @IBJHealthcare | @IBJDining |
| @IBJLists | @IBJSmallbiz | |
ADVERTISEMENT
Back to TopCopyright © All Rights Reserved. Privacy Policy | Terms of Use.
Design, CMS, Hosting & Web Development :: ePublishing.
Additional Hosting & Delivery by
I'd rather the state keep my $7 instead of sending $3 to me and $4 to some attorney.
Hey Horace, I totally support your right for freedom of religious expression as well as your right to take this class. BUT I do believe this class should be presented as part of a religion curriculum and not as a science course.
Gob Bluth
Scotty's Lakeside at Geist was SO much better than this new Detour. We enjoyed the family nights, atmosphere, food and selection of local beers at Scotty's Lakeside. The new Detour has a lower level of service and we were not impressed with the food and beer selections. Would love to have Scotty's Lakeside back!!!
I have only been to The Precedent Scotty's location, but food and service have been consistently good and they are always packed. I'd love to say 'good-bye' to Detour(big babies). Since that area is built and intended to a mix of residential and business, there should not be any kind of noise level that would disturb any of the homeowners or patrons nearby. I've been to Detour only once (all it takes for me) and the food was so-so and overpriced and the service was under-par. Keep on trucking Mr. Wise!